nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—atherosclerosis	0.268	1	CbGaD
Phenylbutazone—SLC22A11—Pravastatin—atherosclerosis	0.161	0.301	CbGbCtD
Phenylbutazone—SLC22A8—Pravastatin—atherosclerosis	0.0938	0.175	CbGbCtD
Phenylbutazone—SLC22A6—Pravastatin—atherosclerosis	0.0654	0.122	CbGbCtD
Phenylbutazone—CYP2C9—Rosuvastatin—atherosclerosis	0.033	0.0616	CbGbCtD
Phenylbutazone—CYP2C9—Simvastatin—atherosclerosis	0.0307	0.0573	CbGbCtD
Phenylbutazone—CYP2C9—Lovastatin—atherosclerosis	0.03	0.056	CbGbCtD
Phenylbutazone—CYP2C9—Pravastatin—atherosclerosis	0.03	0.056	CbGbCtD
Phenylbutazone—CYP3A4—Rosuvastatin—atherosclerosis	0.0192	0.0358	CbGbCtD
Phenylbutazone—CYP3A4—Ezetimibe—atherosclerosis	0.0192	0.0358	CbGbCtD
Phenylbutazone—CYP3A4—Simvastatin—atherosclerosis	0.0178	0.0333	CbGbCtD
Phenylbutazone—CYP3A4—Pravastatin—atherosclerosis	0.0174	0.0326	CbGbCtD
Phenylbutazone—CYP3A4—Lovastatin—atherosclerosis	0.0174	0.0326	CbGbCtD
Phenylbutazone—PTGIS—artery—atherosclerosis	0.00835	0.156	CbGeAlD
Phenylbutazone—PTGIS—endothelium—atherosclerosis	0.00706	0.132	CbGeAlD
Phenylbutazone—PTGIS—blood vessel—atherosclerosis	0.00651	0.121	CbGeAlD
Phenylbutazone—PTGIS—connective tissue—atherosclerosis	0.00334	0.0622	CbGeAlD
Phenylbutazone—PTGIS—cardiovascular system—atherosclerosis	0.0029	0.0541	CbGeAlD
Phenylbutazone—PTGS2—leg—atherosclerosis	0.00273	0.051	CbGeAlD
Phenylbutazone—PTGIS—adipose tissue—atherosclerosis	0.00256	0.0478	CbGeAlD
Phenylbutazone—PTGS2—hindlimb—atherosclerosis	0.00244	0.0455	CbGeAlD
Phenylbutazone—PTGS2—appendage—atherosclerosis	0.00209	0.0391	CbGeAlD
Phenylbutazone—PTGIS—liver—atherosclerosis	0.0018	0.0335	CbGeAlD
Phenylbutazone—PTGS1—artery—atherosclerosis	0.00157	0.0292	CbGeAlD
Phenylbutazone—PTGS2—artery—atherosclerosis	0.0015	0.0279	CbGeAlD
Phenylbutazone—PTGS1—endothelium—atherosclerosis	0.00132	0.0247	CbGeAlD
Phenylbutazone—PTGS2—endothelium—atherosclerosis	0.00126	0.0236	CbGeAlD
Phenylbutazone—PTGS1—blood vessel—atherosclerosis	0.00122	0.0227	CbGeAlD
Phenylbutazone—PTGS2—blood vessel—atherosclerosis	0.00117	0.0217	CbGeAlD
Phenylbutazone—SLC22A11—liver—atherosclerosis	0.001	0.0187	CbGeAlD
Phenylbutazone—PTGS1—connective tissue—atherosclerosis	0.000625	0.0117	CbGeAlD
Phenylbutazone—PTGS2—connective tissue—atherosclerosis	0.000598	0.0111	CbGeAlD
Phenylbutazone—CYP2C9—cardiovascular system—atherosclerosis	0.000596	0.0111	CbGeAlD
Phenylbutazone—PTGS1—cardiovascular system—atherosclerosis	0.000544	0.0101	CbGeAlD
Phenylbutazone—PTGS2—cardiovascular system—atherosclerosis	0.00052	0.0097	CbGeAlD
Phenylbutazone—PTGS1—adipose tissue—atherosclerosis	0.00048	0.00895	CbGeAlD
Phenylbutazone—PTGS2—adipose tissue—atherosclerosis	0.000458	0.00855	CbGeAlD
Phenylbutazone—CYP2C9—liver—atherosclerosis	0.000368	0.00687	CbGeAlD
Phenylbutazone—PTGS2—liver—atherosclerosis	0.000322	0.006	CbGeAlD
Phenylbutazone—Diphenhydramine—HRH1—atherosclerosis	0.000313	0.318	CrCbGaD
Phenylbutazone—CYP3A4—liver—atherosclerosis	0.000281	0.00524	CbGeAlD
Phenylbutazone—Oxaprozin—PTGS2—atherosclerosis	0.000225	0.229	CrCbGaD
Phenylbutazone—Fosphenytoin—ALB—atherosclerosis	0.000209	0.213	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—atherosclerosis	0.000143	0.146	CrCbGaD
Phenylbutazone—Phenytoin—ALB—atherosclerosis	9.22e-05	0.0939	CrCbGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.39e-05	0.000168	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPA—atherosclerosis	2.38e-05	0.000168	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOA2—atherosclerosis	2.37e-05	0.000167	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NOS3—atherosclerosis	2.36e-05	0.000167	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.35e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LCAT—atherosclerosis	2.35e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FABP4—atherosclerosis	2.35e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BGN—atherosclerosis	2.31e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA4—atherosclerosis	2.3e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.29e-05	0.000162	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOA5—atherosclerosis	2.29e-05	0.000161	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	2.27e-05	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP7A1—atherosclerosis	2.26e-05	0.00016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.24e-05	0.000158	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.23e-05	0.000158	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.22e-05	0.000157	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.22e-05	0.000157	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.21e-05	0.000156	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PLA2G1B—atherosclerosis	2.2e-05	0.000155	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BGN—atherosclerosis	2.19e-05	0.000154	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.18e-05	0.000154	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—atherosclerosis	2.16e-05	0.000152	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.16e-05	0.000152	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.16e-05	0.000152	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.16e-05	0.000152	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.15e-05	0.000152	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALOX5—atherosclerosis	2.12e-05	0.00015	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.11e-05	0.000149	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP27A1—atherosclerosis	2.09e-05	0.000148	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.09e-05	0.000148	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.09e-05	0.000148	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.07e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.06e-05	0.000145	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.05e-05	0.000145	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—atherosclerosis	2.01e-05	0.000142	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.01e-05	0.000142	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	2e-05	0.000141	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA2—atherosclerosis	1.98e-05	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLA2G2A—atherosclerosis	1.98e-05	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALOX5AP—atherosclerosis	1.98e-05	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALOX15—atherosclerosis	1.98e-05	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.96e-05	0.000139	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCG5—atherosclerosis	1.96e-05	0.000138	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.96e-05	0.000138	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.95e-05	0.000138	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK3—atherosclerosis	1.92e-05	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.91e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CST3—atherosclerosis	1.91e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NAMPT—atherosclerosis	1.91e-05	0.000135	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.89e-05	0.000134	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LIPC—atherosclerosis	1.89e-05	0.000134	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPA—atherosclerosis	1.89e-05	0.000134	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOC3—atherosclerosis	1.88e-05	0.000133	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LDLR—atherosclerosis	1.87e-05	0.000132	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—atherosclerosis	1.86e-05	0.000132	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BGN—atherosclerosis	1.83e-05	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CETP—atherosclerosis	1.83e-05	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.82e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA5—atherosclerosis	1.81e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NAMPT—atherosclerosis	1.81e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOC3—atherosclerosis	1.78e-05	0.000126	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LDLR—atherosclerosis	1.77e-05	0.000125	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.76e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SCARB1—atherosclerosis	1.75e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.75e-05	0.000123	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.74e-05	0.000123	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.73e-05	0.000122	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HSPA1B—atherosclerosis	1.71e-05	0.000121	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.71e-05	0.000121	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.71e-05	0.00012	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.7e-05	0.00012	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.69e-05	0.000119	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALOX5—atherosclerosis	1.69e-05	0.000119	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NCF1—atherosclerosis	1.66e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.65e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMGCR—atherosclerosis	1.65e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLTP—atherosclerosis	1.59e-05	0.000112	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CYBA—atherosclerosis	1.56e-05	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.56e-05	0.00011	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LCAT—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FABP4—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PARP1—atherosclerosis	1.53e-05	0.000108	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA4—atherosclerosis	1.53e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NAMPT—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOC3—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LDLR—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCA1—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CETP—atherosclerosis	1.45e-05	0.000102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.42e-05	0.000101	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—atherosclerosis	1.4e-05	9.92e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SCARB1—atherosclerosis	1.39e-05	9.81e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.39e-05	9.78e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.38e-05	9.74e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.38e-05	9.74e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.36e-05	9.63e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.35e-05	9.55e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.33e-05	9.4e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.31e-05	9.27e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA2—atherosclerosis	1.31e-05	9.27e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.31e-05	9.27e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.31e-05	9.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMGCR—atherosclerosis	1.31e-05	9.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.3e-05	9.16e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.3e-05	9.15e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—atherosclerosis	1.3e-05	9.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMOX1—atherosclerosis	1.26e-05	8.92e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPA—atherosclerosis	1.25e-05	8.85e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BGN—atherosclerosis	1.21e-05	8.57e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOB—atherosclerosis	1.21e-05	8.54e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.21e-05	8.51e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA5—atherosclerosis	1.2e-05	8.48e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—atherosclerosis	1.18e-05	8.31e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCA1—atherosclerosis	1.17e-05	8.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.17e-05	8.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.16e-05	8.16e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPL—atherosclerosis	1.16e-05	8.16e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOB—atherosclerosis	1.15e-05	8.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.14e-05	8.07e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.13e-05	8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.13e-05	7.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX1—atherosclerosis	1.13e-05	7.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.12e-05	7.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD36—atherosclerosis	1.1e-05	7.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LPL—atherosclerosis	1.1e-05	7.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.09e-05	7.7e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—atherosclerosis	1.09e-05	7.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCG—atherosclerosis	1.07e-05	7.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—atherosclerosis	1.04e-05	7.35e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.03e-05	7.29e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.03e-05	7.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.03e-05	7.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARA—atherosclerosis	1.02e-05	7.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.01e-05	7.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMOX1—atherosclerosis	1e-05	7.08e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NAMPT—atherosclerosis	1e-05	7.07e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.96e-06	7.03e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LIPC—atherosclerosis	9.96e-06	7.03e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOC3—atherosclerosis	9.89e-06	6.98e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	9.89e-06	6.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGT—atherosclerosis	9.89e-06	6.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—atherosclerosis	9.86e-06	6.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LDLR—atherosclerosis	9.83e-06	6.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—atherosclerosis	9.69e-06	6.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOB—atherosclerosis	9.61e-06	6.78e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CETP—atherosclerosis	9.61e-06	6.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFB—atherosclerosis	9.6e-06	6.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAV1—atherosclerosis	9.6e-06	6.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOA1—atherosclerosis	9.58e-06	6.76e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—atherosclerosis	9.35e-06	6.6e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.2e-06	6.49e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—atherosclerosis	9.18e-06	6.48e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPL—atherosclerosis	9.18e-06	6.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.14e-06	6.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CAV1—atherosclerosis	9.1e-06	6.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOA1—atherosclerosis	9.08e-06	6.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.96e-06	6.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX1—atherosclerosis	8.95e-06	6.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—atherosclerosis	8.74e-06	6.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD36—atherosclerosis	8.72e-06	6.15e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMGCR—atherosclerosis	8.69e-06	6.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.66e-06	6.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.66e-06	6.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.66e-06	6.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA2—atherosclerosis	8.66e-06	6.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.56e-06	6.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—atherosclerosis	8.56e-06	6.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—atherosclerosis	8.44e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—INS—atherosclerosis	8.28e-06	5.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPA—atherosclerosis	8.27e-06	5.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—atherosclerosis	8.26e-06	5.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARA—atherosclerosis	8.1e-06	5.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BGN—atherosclerosis	8.01e-06	5.65e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA5—atherosclerosis	7.92e-06	5.59e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGT—atherosclerosis	7.85e-06	5.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—INS—atherosclerosis	7.85e-06	5.54e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.84e-06	5.53e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.74e-06	5.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—atherosclerosis	7.69e-06	5.43e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.63e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAV1—atherosclerosis	7.62e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA1—atherosclerosis	7.6e-06	5.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—atherosclerosis	7.59e-06	5.36e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.37e-06	5.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—atherosclerosis	7.26e-06	5.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—atherosclerosis	7.21e-06	5.09e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—atherosclerosis	6.94e-06	4.9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—atherosclerosis	6.88e-06	4.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—atherosclerosis	6.7e-06	4.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.64e-06	4.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—atherosclerosis	6.64e-06	4.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.61e-06	4.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—INS—atherosclerosis	6.57e-06	4.64e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LIPC—atherosclerosis	6.57e-06	4.63e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOC3—atherosclerosis	6.53e-06	4.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDLR—atherosclerosis	6.49e-06	4.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOB—atherosclerosis	6.36e-06	4.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CETP—atherosclerosis	6.34e-06	4.47e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.19e-06	4.37e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPL—atherosclerosis	6.08e-06	4.29e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.07e-06	4.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—atherosclerosis	6.02e-06	4.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX1—atherosclerosis	5.93e-06	4.18e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD36—atherosclerosis	5.77e-06	4.07e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—atherosclerosis	5.76e-06	4.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.73e-06	4.04e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.47e-06	3.86e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARA—atherosclerosis	5.37e-06	3.79e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGT—atherosclerosis	5.2e-06	3.67e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.11e-06	3.6e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—atherosclerosis	5.09e-06	3.59e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAV1—atherosclerosis	5.05e-06	3.56e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA1—atherosclerosis	5.03e-06	3.55e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—atherosclerosis	4.91e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK3—atherosclerosis	4.69e-06	3.31e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.6e-06	3.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—atherosclerosis	4.55e-06	3.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—atherosclerosis	4.44e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.38e-06	3.09e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—INS—atherosclerosis	4.35e-06	3.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOB—atherosclerosis	4.2e-06	2.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.08e-06	2.88e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPL—atherosclerosis	4.01e-06	2.83e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—atherosclerosis	3.99e-06	2.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX1—atherosclerosis	3.91e-06	2.76e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—atherosclerosis	3.82e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD36—atherosclerosis	3.81e-06	2.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.61e-06	2.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARA—atherosclerosis	3.54e-06	2.5e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.49e-06	2.46e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGT—atherosclerosis	3.43e-06	2.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—atherosclerosis	3.43e-06	2.42e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—atherosclerosis	3.36e-06	2.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—atherosclerosis	3.34e-06	2.35e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAV1—atherosclerosis	3.33e-06	2.35e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA1—atherosclerosis	3.32e-06	2.34e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—atherosclerosis	3.16e-06	2.23e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.03e-06	2.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—atherosclerosis	2.93e-06	2.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—INS—atherosclerosis	2.87e-06	2.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—atherosclerosis	2.65e-06	1.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—atherosclerosis	2.63e-06	1.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—atherosclerosis	2.52e-06	1.78e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.3e-06	1.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—atherosclerosis	1.75e-06	1.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.16e-06	8.16e-06	CbGpPWpGaD
